
BioXcel Therapeutics Inc. (NASDAQ:BTAI) Falls -45.90% In 2023; Is It Still Attractive At $3.34?
In last trading session, BioXcel Therapeutics Inc. (NASDAQ:BTAI) saw 3.88 million shares changing hands with its beta currently measuring 0.99. Company’s recent per share price